Showing results (311-320 of 586) with videos related to

Sort By:
Pageof 59
The Journal of Chemical Physics|May 17, 2011
Robust three-body water simulation modelC J Tainter, P A Pieniazek, Y-S Lin, et al.
Immunology Letters|February 1, 1997
V beta 8+CD4-CD8- subpopulation induced by staphylococcal enterotoxin BM C Chou, S C Lee, Y S Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1989
Immunomodulatory activity of staphylococcal enterotoxin-B. The induction of an I-J-restricted suppressor factorD D Taub, Y S Lin, S C Hu, et al.
Anesthesia Progress|November 1, 1988
Reflex bronchospasm-induced acute massive pulmonary collapseS C Lee, Y S Lin, K J Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1992
Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunitM Zhang, P D Zamore, M Carmo-Fonseca, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1995
Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery GroupD J Sugarbaker, J Herndon, L J Kohman, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|December 13, 2005
The development of the UK radon programmeG M Kendall, B M R Green, J C H Miles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavityM Markman, S B Howell, W E Lucas, et al.
Science (New York, N.Y.)|October 22, 1993
The conserved pre-mRNA splicing factor U2AF from Drosophila: requirement for viabilityR Kanaar, S E Roche, E L Beall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology GroupG Clamon, J Herndon, R Cooper, et al.
Pageof 59